Patrick McCall

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Piper Sandler & Co. (Broker) (PSC-Broker) is the full-service brokerage division of Piper Sandler & Co., a financial service firm headquartered in Minneapolis, Minnesota. They are a subsidiary of Piper Sandler Companies (NYSE: PIPR). The firm was founded in 1969 and previously known as Piper Jaffray & Co. They became Piper Sandler & Co. when Piper Jaffray Companies and Sandler O’Neill & Partners, L.P. merged to become Piper Sandler Companies in 2020. PSC-Broker provides brokerage and investment banking services to financial institutions, corporations and other financial investors. Their core focus sectors are Agriculture, renewables & cannabis, Business services, Chemicals & Materials, Consumer, Diversified industrials & services, Energy, Financial services, financial sponsors, Healthcare, and Technology.

Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA.

410 Medical, Inc. operates as a medical device company. It develops LifeFlow for fluid resuscitation to help patients with life-threatening illnesses such as sepsis. The company was founded by Mark Donald Piehl and Luke Miller Roush in 2013 and is headquartered in Durham, NC.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA.

Mosaic Biomedicals SL develops personalized cancer treatments. It is engaged in the realization and development of scientific and technical research projects in the field of oncological and tumor diseases. The company was founded by Joan Seoane, Judit Anido Folgueira and José Baselga on April 19, 2013 and is headquartered in Barcelona, Spain.

Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada.

Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada.

Verily Life Sciences LLC provides healthcare solutions for global markets. The firm specializes in healthcare, hardware, software, clinical studies, scientific research, disease management platforms, sensors, population health management and precision medicine. It develops tools to collect and organize health data. The company is headquartered in South San Francisco, CA.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

Entrinsic, Inc. operates as a health sciences company. It develops and commercializes amino acid based medical foods to address critical digestive health, nutrition and hydration related health issues. The company was founded by Sadasivan Vidyasagar and Paul Okunieff in 2014 and is headquartered in Norwood, MA.

Grove Ventures Capital (GP) Ltd (Grove Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Tel Aviv, Israel.

Benchsci Analytics, Inc. develops and operates an online platform that extracts usage evidence from scientific papers and organizes it around antibodies. Its platform allows scientists to search millions of papers to find antibody usage data. The company was founded by Liran Belenzon, David Qixiang Chen, Thomas KH Leung, and Elvis Wiandas and is headquartered in Toronto, Canada.

BIOS Capital Management LP (BIOS Partners) is a venture capital firm founded in 2014 by Stella Robertson, Aaron Fletcher and Leslie Kreis. The firm is headquartered in Fort Worth, Texas.

Part of BIOS Capital Management LP, BIOS Equity Partners LP functions as a private equity firm. The company is based in Texas. The American company was founded by Leslie W. Kreis.

The Massachusetts Board of Bar Overseers operates as an independent administrative body that investigates and evaluates complaints against lawyers. The private company is based in Boston.

Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

Part of Seed Health, Inc., LUCA Biologics, Inc. is a biotechnology company based in Boston, MA. LUCA Biologics is developing a new class of microbe-based therapies to treat unmet medical needs in women's health. The company's proprietary bioinformatics platform is powered by the largest integrated dataset of vaginal metagenomes and metatranscriptomes catalogued to date. The company's novel gene-centric model informs their pipeline of Vaginal Microbiota Stabilization Consortia (VMSCs) designed to modulate the vaginal microbiota for the prevention and treatment of disease. LUCA Biologics is a biotechnology company developing a new class of living medicines targeting the vaginal microbiome to impact reproductive and urogenital health. The company was founded by Luba Greenwood.

Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States.

Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands.

Filament BioSolutions, Inc. develops medical and functional foods for diseases. The company is based in Long Island City, NY. The company was founded by Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation.

Immunovent LLC is a biotech company based in New York, NY. Immunovent is revolutionizing allergy diagnostics by coupling existing clinical practices with their patented lamb-dx test. The lamb-dx test detects small amounts of antigen-specific ige from symptomatic areas of the body, such as the mouth and the nose, through a gentle and easy mucosal brush sampling procedure and a proprietary diagnostic assay. This allows for the rapid and safe diagnosis of common allergies without the inconveniences and issues of conventional skin prick and blood testing. The private company was founded by Kate Rochlin and Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation.

OS Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on January 13, 2021 and is headquartered in Park Ridge, IL.

SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki.

Scinapsis Analytics, Inc., also known as BenchSci, is a company based in Toronto, Canada. BenchSci is a world leader in AI solutions for preclinical R&D. The Canadian company provides resources to help organizations make the most of their platform, which leads to quantifiable productivity gains, recouped research capacity, and a reduction in spend. The company's proprietary technology helps decode the complexity of biomedical research. Scinapsis Analytics, Inc. also offers ASCEND, an innovative platform that empowers scientists to optimize their experimental approach at every stage of drug discovery. The company was founded by Pushparaj Abhi.